Hyperkalemia in heart failure: Foe or friend?-Reference-Cited by-同舟云学术

Hyperkalemia in heart failure: Foe or friend?

Published:2020-05-23 Issue:7 Volume:43 Page:666-675
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Rakisheva Amina¹^ORCID,Marketou Maria²^ORCID,Klimenko Anna³,Troyanova‐Shchutskaia Tatyana⁴,Vardas Panos⁵

Affiliation:

1. Department of CardiologyScientific Institution of Cardiology and Internal Diseases Almaty Kazakhstan

2. Department of CardiologyHeraklion University Hospital Crete Greece

3. RUDN University Moscow Russian Federation

4. Department of CardiologyScientific and Practical Center of Cardiology Minsk Belarus

5. Department of CardiologyHeart Sector, Hygeia Hospitals Group Athens Greece

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23392

Reference61 articles.

1. Epidemiology and aetiology of heart failure

2. Neurohormonal activation in heart failure with reduced ejection fraction

3. Expert consensus document on the management of hyperkalemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology;Rosano GCM;Eur Heart J,2018

4. Hyperkalemia in heart failure patients: current challenges and future prospects;Lopez Vilella R;Res Rep Clin Cardiol,2016

5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Feature Selection-Incorporated Simulation Study to Reveal the Effect of Calcium Ions on Cardiac Repolarization Alternans during Myocardial Ischemia;Applied Sciences;2024-08-03

2. Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem;Cardiovascular Drugs and Therapy;2024-01-30

3. Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice;The Egyptian Heart Journal;2023-08-21

4. Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis;ESC Heart Failure;2023-07-02

5. The Efficacy and Safety of Patiromer for Heart Failure Patients: A Systematic Review and Meta-Analysis;Cardiovascular Drugs and Therapy;2023-06-07